Insider Dennis Mulroy plans ANAB (NASDAQ: ANAB) Rule 144 sale filing
Rhea-AI Filing Summary
AnaptysBio (symbol ANAB) disclosed a planned insider sale of common stock under Rule 144. The notice covers 2,515 shares of common stock to be sold through Morgan Stanley Smith Barney LLC on NASDAQ, with an aggregate market value of 113,703.15. These shares come from restricted stock units acquired from the issuer on 01/08/2026, with cash as the form of payment.
The filing also lists recent sales by Dennis Mulroy over the prior three months. These include 1,908 shares sold on 01/07/2026 for 83,780.28, 3,363 shares on 01/05/2026 for 1,511,166.85, 10,000 shares on 12/22/2025 for 500,000, and 15,725 shares on 12/16/2025 for 705,333.1. The Rule 144 representation confirms the seller states they are not aware of undisclosed material adverse information about the issuer.
Positive
- None.
Negative
- None.
FAQ
What does the ANAB Form 144 filing disclose?
Who is selling ANAB shares in this Form 144 notice?
What is the source of the 2,515 ANAB shares to be sold?
What recent ANAB stock sales by Dennis Mulroy are reported?
How many ANAB shares are outstanding as referenced in the filing?
What representation does the seller make in the ANAB Form 144?